P&G Manages Production Demands 'Day To Day' As Consumer Health Brands Drive Growth In Pandemic
Executive Summary
P&G reported personal health care brands drove overall health care organic sales up 9% to $2.26bn in its latest quarter. CFO Jon Moeller says consumer stockpiling caused production acceleration as its five largest North American plants in March increased production 22% over monthly average for previous year.
You may also be interested in...
After 5% Sales Growth In Its FY 2020, P&G Bullish For 2021 Despite Looming Economic Threats
Macro factors that could hamper results include the economic recession caused by businesses’ reactions to novel coronavirus pandemic, the impact of COVID-19 on consumer buying trends and disruptions to supply chains.
'Positive' Signs Abound For Perrigo, But 'Uncertainty' From Pandemic Complicates Outlook
"With all the positive things, I'd normally be raising guidance right now," says CEO Murray Kessler as Perrigo reports first-quarter results. But manufacturing operations aren't normal, and neither is the consumer health product marketplace.
C&D Boosts Gummy Vitamin Manufacturing As Consumer Stockpiling ‘Wiped Out’ Supply
Church & Dwight invests in two manufacturing plants to increase production of its vitafusion and L’il Critters gummies after COVID-19-related stockpiling clears many customers' inventories. Demand for the products and nasal hygiene helped drive 10.2% domestic consumer sales increase in the first quarter.